Free. Unsubscribe any time.
Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. filed 5 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 5 transactions and 66,452 shares. None carries the SEC's AFF10B5ONE flag; all 5 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-06-30, came 146 days after the one before it (2026-02-04) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 18,000 shares, 3,000 more than the 15,000 in the filing before it.
- Its 5 filings on file run from 2025-11-21 to 2026-06-30, and state 3 plan adoption dates, from 2025-08-01 to 2026-03-27.
Trades in Fulcrum Therapeutics, Inc. 5
- Gould Robert J — 2025-11-19 · S · 15,000 shares
- Oltmans Curtis Gale — 2025-12-15 · S · 3,452 shares
- Gould Robert J — 2026-01-02 · S · 15,000 shares
- Gould Robert J — 2026-01-02 · S · 15,000 shares
- Ezekowitz Alan — 2026-06-26 · S · 18,000 shares
Adoption dates in Fulcrum Therapeutics, Inc. 3
- 2025-08-01 — stated in 3 filings
- 2025-08-08 — stated in 1 filing
- 2026-03-27 — stated in 1 filing
Results prints in Fulcrum Therapeutics, Inc. 0
Trades before a print in Fulcrum Therapeutics, Inc. 0
Interval to Fulcrum Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 5no later print
Adoption dates Fulcrum Therapeutics, Inc. states
- 2025-08-01 in 3 filings
- 2025-08-08 in 1 filing
- 2026-03-27 in 1 filing
Filing text: “10b5-1 trading plan adopted by the reporting person on August 1, 2025”
Sources: SEC EDGAR full-text search and the SEC submissions API.